Efficacy and Safety of Epirubicin Combined with Temozolomide for Treatment of Advanced Leiomyosarcoma.

Huijing TanLijie ZuoShutao Ma Ding-Yuan WangRui LiYiqi Yang Weili LiuYihebali Chi

Published in: Cancer management and research (2021)

EPI-TMZ is potentially effective for treatment of advanced LMS, and the adverse effects appear tolerable. EPI-TMZ provided better outcomes than reported in previous studies of other treatments for advanced LMS.

Keyphrases

metabolic syndrome
adipose tissue
skeletal muscle
case control